Suppr超能文献

恶性黑色素瘤的联合免疫疗法。脑转移后的异常生存期。

Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.

作者信息

Spitler L E, Wong P, Sagebiel R

出版信息

Arch Dermatol. 1978 Oct;114(10):1501-4.

PMID:718187
Abstract

An 18-year-old woman was found to have solitary cerebral, choroidal, and pulmonary metastases of malignant melanoma three years after excision of a primary malignant melanoma. The cerebral metastasis was excised, and the patient's condition was treated with CNS irradiation followed by combined immunotherapy with transfer factor and Bacille bilié de Calmette-Guérin. The transfer factor donor was her father, who showed cellular immunity to melanoma extracts on in vitro testing. Histologic examination of the pulmonary nodule, which was excised after the initiation of immunotherapy, revealed a dense lymphocytic infiltrate associated with the metastatic melanoma. The patient is currently free of detectable melanoma more than three years after the cerebral metastasis. Studies in a second patient also demonstrated the appearance of inflammatory infiltrate in metastatic melanoma following transfer factor therapy.

摘要

一名18岁女性在原发性恶性黑色素瘤切除三年后,被发现患有孤立性脑、脉络膜和肺转移瘤。切除了脑转移瘤,患者接受了中枢神经系统放疗,随后用转移因子和卡介苗进行联合免疫治疗。转移因子供体是她的父亲,体外检测显示其对黑色素瘤提取物具有细胞免疫。免疫治疗开始后切除的肺结节组织学检查显示,转移性黑色素瘤伴有密集的淋巴细胞浸润。该患者在脑转移后三年多目前未检测到黑色素瘤。对第二名患者的研究也表明,转移因子治疗后转移性黑色素瘤出现炎症浸润。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验